Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
10
self-reported band not used
Founded
2017
9 years
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
1
Series A · Oct 2024
Company type
Public Company
self-reported
Legal entity
1 brand → 1 confirmed entity
NEOPHARMA TECHNOLOGIES LIMITED
ABN31619487133
Legal entities
Show as table · Neopharma Technologies Limited: 1 registry entity
| NEOPHARMA TECHNOLOGIES LIMITED | ABN 31619487133 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Neopharma Technologies Ltd has three integrated proprietary technologies for the Drug Testing Industry: myNEO® app, NEOVAULT™ app and NEOVAULT™, for simple, secure, paperless drug testing.
Neopharma Technologies IT Platform has 3 parts:
1. myNEO® app that is used by the end user (donor).
2. NEOVAULT™ app that is utilised by the Tester/Supervisor 3. NEOVAULT™ platform which sits in head office run either by the head of HR or the senior company administrator.
The apps are available on Apple and Google Play Stores.
This proprietary technology is a leader in the digital collection and interpretation of test data via a short 3 second video as opposed to multiple static images.
Neopharma’s technology has achieved the highest of international cyber security standards over the last 18 months achieving SOC2 Type II, HIPPA, GDPR & ISO 27001 certifications.
Benefits for Manufacturers:
Creating additional Revenue Stream’s.
myNEO® – Step by Step Instructions, Instructional Video, AI Test Strip data recording and interpretation, Digital Health Reporting. Providing a marketing advantage and an additional revenue stream for NEOVAULT enabled test kits.
NEOVAULT app – simplifies and secures the testing process for TPA’s providing time and cost savings. With a good adoption of the NEOVAULT Platform, sales will increase for NEOVAULT enabled test kits.
NEOVAULT Platform – new test kits can be incorporated into the NEOVAULT platform to produce the step-by-step instructions and linked to our AI Image Test Strip Recognition for any new test kit.
Benefits for Third Party Administrators (TPA’s):
- Significant Time and Cost Savings
- Paperless, AI Image Recognition, More Efficient Workflow.
- Provides simple step-by-step instruction at all stages of the testing process.
- Provides a chain of custody.
- Provides real time reporting to head office.
- Minimises the risk of human error.
Safe Workplace Best Practice
Specialties
All 9 specialties
- Drug Testing
- Drug of Abuse Testing Research & Design
- Information Systems
- Integrated Systems
- Presumptive Diagnostics
- Life Sciences
- Medical Devices
- AI
- Rapid Testing
Related specialties
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AULevel 4, 16 St Georges Tce; Perth , Western Australia 6000Primary
Grid intelligence Members
Funding
Last round · 24 October 2024Amount not recordedSeries A
Rounds1
Round typeSeries A · venture round
Amount (USD)not recorded
Stage rank3
Investors named0
Since last round1 yr 2 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 2017 to 2026 |
| Series A · 24 Oct 2024 | not disclosed |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
Which legal entity operates under Neopharma Technologies Limited?
One Western Australia entity on the ABR. NEOPHARMA TECHNOLOGIES LIMITED (ABN 31 619 487 133), high confidence.
How many people work at Neopharma Technologies Limited?
The record holds 10 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.
Where does Neopharma Technologies Limited have offices?
One address on record, Australia only. Primary: Level 4, 16 St Georges Tce, Perth, Western Australia 6000.
Has Neopharma Technologies Limited raised funding?
One round. Latest 24 October 2024: Series A, no amount recorded.
What does Neopharma Technologies Limited list as its specialties?
Nine tags on the brand's own list, among them life sciences, information systems and ai.
Which companies are listed alongside Neopharma Technologies Limited?
4 profiles list Neopharma Technologies Limited as a peer — 69th percentile in Medical Device. It lists ten peers of its own. LithTech Industries and Push Climbing list it back.